Melanoma/Skin Cancer News

Disease regression was associated with improved recurrence-free survival and overall survival among certain patients with stage 1 and 2 cutaneous melanomas, according to a study.

Cutaneous oncology news in 2020 included important studies, FDA approvals and research into the causes of melanoma in different populations.

Melanoma development in skin of color may not be exacerbated by UV exposure, according to a study published in JAMA Dermatology.

Local recurrence rates of male genital skin cancer were low for patients who underwent Mohs micrographic surgery, according to a study published in Journal of the American Academy of Dermatology.

Actin expression may be the root of muscle spasms in patients with basal cell carcinoma who are treated with Hedgehog inhibitors, according to a study.

The Society for Immunotherapy of Cancer created the Steven A. Rosenberg, MD, PhD, Endowed Scholars Fund.

Recurrent basal cell carcinomas and primary basal cell carcinomas have a high likelihood of recurrence, according to a presentation at the European Academy of Dermatology and Venereology virtual congress.

Multiple subtypes and clinical presentations of pediatric melanoma led to fatal disease, according to a study.

Lesbian, gay, bisexual, transgender or queer individuals, or sexual and gender minorities, have been shown to have a disproportionate risk for cancer.

A study of U.S. kidney transplant recipients showed no significant changes in cancer incidence during a period of 3 decades, with rates of graft failure and mortality remaining high.